BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9623737)

  • 1. Glycosaminoglycans in thyroid eye disease.
    Kahaly G; Förster G; Hansen C
    Thyroid; 1998 May; 8(5):429-32. PubMed ID: 9623737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPLC glycosaminoglycan analysis in patients with Graves' disease.
    Hansen C; Fraiture B; Rouhi R; Otto E; Förster G; Kahaly G
    Clin Sci (Lond); 1997 May; 92(5):511-7. PubMed ID: 9176026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased sulfatation of orbital glycosaminoglycans in Graves' ophthalmopathy.
    Hansen C; Rouhi R; Förster G; Kahaly GJ
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1409-13. PubMed ID: 10199787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of human urinary hyaluronic acid, chondroitin sulphate and dermatan sulphate as their unsaturated disaccharides by high-performance liquid chromatography.
    Toyoda H; Motoki K; Tanikawa M; Shinomiya K; Akiyama H; Imanari T
    J Chromatogr; 1991 Apr; 565(1-2):141-8. PubMed ID: 1908476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosaminoglycans provide a binding site for thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathy.
    Marinò M; Lisi S; Pinchera A; Marcocci C; Menconi F; Morabito E; Macchia M; Sellari-Franceschini S; McCluskey RT; Chiovato L
    Thyroid; 2003 Sep; 13(9):851-9. PubMed ID: 14588099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary glycosaminoglycans in Graves' ophthalmopathy.
    Kahaly G; Schuler M; Sewell AC; Bernhard G; Beyer J; Krause U
    Clin Endocrinol (Oxf); 1990 Jul; 33(1):35-44. PubMed ID: 2401097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H-magnetic resonance spectroscopy of retrobulbar tissue in Graves ophthalmopathy.
    Ohtsuka K; Hashimoto M
    Am J Ophthalmol; 1999 Dec; 128(6):715-9. PubMed ID: 10612507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosaminoglycans of skin and urine in pseudoxanthoma elasticum: evidence for chondroitin 6-sulfate alteration.
    Longas MO; Wisch P; Lebwohl MG; Fleischmajer R
    Clin Chim Acta; 1986 Mar; 155(3):227-36. PubMed ID: 3085984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The assessment of urinary glycosaminoglycans (GAG) excretion during therapy of patients with progressive Graves' ophthalmopathy].
    Pilarska K; Kulig G; Krzystolik Z
    Pol Arch Med Wewn; 2001 Feb; 105(2):139-44. PubMed ID: 11505748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary glycosaminoglycan (uGAG) excretion in healthy pediatric and adolescent population.
    Komosinska-Vassev K; Blat D; Olczyk P; Szeremeta A; Jura-Półtorak A; Winsz-Szczotka K; Klimek K; Olczyk K
    Clin Biochem; 2014 Sep; 47(13-14):1341-3. PubMed ID: 24956269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosaminoglycans in autoimmunity.
    Hansen C; Otto E; Kuhlemann K; Förster G; Kahaly GJ
    Clin Exp Rheumatol; 1996; 14 Suppl 15():S59-67. PubMed ID: 8828950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and secretion of glycosaminoglycans in cultured retinal pigment epithelium.
    Stramm LE
    Invest Ophthalmol Vis Sci; 1987 Apr; 28(4):618-27. PubMed ID: 3104227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses.
    Zhang H; Wood T; Young SP; Millington DS
    Mol Genet Metab; 2015 Feb; 114(2):123-8. PubMed ID: 25458519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The metabolism of glycosaminoglycans in the course of Graves' disease].
    Winsz-Szczotka K; Komosińska-Vassev K; Olczyk K
    Postepy Hig Med Dosw (Online); 2006; 60():184-91. PubMed ID: 16618989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of practical methods for urinary glycosaminoglycans and serum hyaluronan with clinical activity scores in patients with Graves' ophthalmopathy.
    Martins JR; Furlanetto RP; Oliveira LM; Mendes A; Passerotti CC; Chiamolera MI; Rocha AJ; Manso PG; Nader HB; Dietrich CP; Maciel RM
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):726-33. PubMed ID: 15163337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An ultrastructural and systemic analysis of glycosaminoglycans in thyroid-associated ophthalmopathy.
    Pappa A; Jackson P; Stone J; Munro P; Fells P; Pennock C; Lightman S
    Eye (Lond); 1998; 12 ( Pt 2)():237-44. PubMed ID: 9683947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of elevated urinary total to sulfated glycosaminoglycan ratio and high molecular mass hyaluronic acid with interstitial cystitis.
    Wei DC; Politano VA; Selzer MG; Lokeshwar VB
    J Urol; 2000 May; 163(5):1577-83. PubMed ID: 10751891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of somatotropin effect on glycosaminoglycan content of canine coronary arteries.
    Sirek OV; Sirek A; Fikar K; Przybylska K
    Endocrinology; 1976 Dec; 99(6):1448-51. PubMed ID: 1001249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment procedure for the microdetermination of chondroitin sulfate in plasma and urine.
    Sakai S; Onose J; Nakamura H; Toyoda H; Toida T; Imanari T; Linhardt RJ
    Anal Biochem; 2002 Mar; 302(2):169-74. PubMed ID: 11878794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary glycosaminoglycans excretion in Graves' disease.
    Priestley GC; Aldridge RD; Hurel S
    Acta Derm Venereol; 1996 Sep; 76(5):368-70. PubMed ID: 8891010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.